![Medicaid Fraud Recoveries Drop Significantly in 2022](https://www.g2intelligence.com/wp-content/uploads/2023/04/May2023.NLR_.2022.MedicaidFraudRecoveries-iStock-1331137712_1100x800-1080x675.jpg)
Medicaid Fraud Recoveries Drop Significantly in 2022
At $1.1 billion, total recoveries in 2022 did exceed $1 billion for the fourth year in a row, but dropped from $1.7 billion in FY 2021
At $1.1 billion, total recoveries in 2022 did exceed $1 billion for the fourth year in a row, but dropped from $1.7 billion in FY 2021
Last week’s lone lab-related enforcement action involved a prison sentence for a woman posing as a licensed physician’s assistant.
The DOJ’s 2022 Fraud Statistics Overview shows it raked in less than 50 percent of what it recovered in FY 2021.
Recent case shows that toxicology labs and drug testing remain a primary target for federal enforcement agencies.
Group of 18 senators says ending Medicare coverage for at-home COVID-19 tests would undo efforts to contain spread of the coronavirus.
On March 28, the 118th Congress raised lab industry hopes once more by reintroducing the Saving Access to Laboratory Services Act (SALSA).
A new OIG Advisory Opinion sheds some light on when it’s permissible for a lab to offer customers a gift card for returning their at-home testing kit.
It’s not just billions of dollars on the line, but the very future of whistleblower lawsuits and FCA enforcement.
The DOJ’s recent report on FCA enforcement statistics for FY 2022 shows that while actions are dramatically up, recoveries are way down.
The three Magellan Diagnostics executives are accused of FDA violations, as well as wire fraud and conspiracy.